Ascentage Pharma Group International (ASPHF)
USD 2.69
(0.0%)
USD 2.69
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.42 Billion CNY | 0.34% |
| 2022 | 2.42 Billion CNY | 42.0% |
| 2021 | 1.7 Billion CNY | 92.82% |
| 2020 | 884.41 Million CNY | 181.15% |
| 2019 | 314.57 Million CNY | -85.96% |
| 2018 | 2.24 Billion CNY | 214.1% |
| 2017 | 713.46 Million CNY | 17.36% |
| 2016 | 607.94 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q2 | 2.31 Billion CNY | 0.0% |
| 2023 Q4 | 2.42 Billion CNY | 0.0% |
| 2023 FY | 2.42 Billion CNY | 0.34% |
| 2023 Q3 | 2.42 Billion CNY | 4.83% |
| 2023 Q1 | 2.31 Billion CNY | -4.28% |
| 2022 Q4 | 2.42 Billion CNY | 0.0% |
| 2022 Q2 | 2.15 Billion CNY | 0.0% |
| 2022 Q1 | 2.15 Billion CNY | 26.55% |
| 2022 FY | 2.42 Billion CNY | 42.0% |
| 2022 Q3 | 2.42 Billion CNY | 12.21% |
| 2021 Q4 | 1.7 Billion CNY | 0.0% |
| 2021 FY | 1.7 Billion CNY | 92.82% |
| 2021 Q3 | 1.7 Billion CNY | 77.95% |
| 2021 Q2 | 958.3 Million CNY | 0.0% |
| 2021 Q1 | 958.3 Million CNY | 8.35% |
| 2020 Q2 | 493.32 Million CNY | 0.0% |
| 2020 FY | 884.41 Million CNY | 181.15% |
| 2020 Q4 | 884.41 Million CNY | 0.0% |
| 2020 Q3 | 884.41 Million CNY | 79.28% |
| 2020 Q1 | 493.32 Million CNY | 56.82% |
| 2019 Q3 | 314.57 Million CNY | -88.33% |
| 2019 Q2 | 2.69 Billion CNY | 0.0% |
| 2019 Q1 | 2.69 Billion CNY | 20.29% |
| 2019 FY | 314.57 Million CNY | -85.96% |
| 2019 Q4 | 314.57 Million CNY | 0.0% |
| 2018 Q3 | 2.24 Billion CNY | 0.0% |
| 2018 FY | 2.24 Billion CNY | 214.1% |
| 2018 Q4 | 2.24 Billion CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2017 FY | 713.46 Million CNY | 17.36% |
| 2016 FY | 607.94 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 53.3 Million USD | -4458.223% |
| Nanobac Pharmaceuticals, Incorporated | 9.58 Million USD | -25257.498% |
| SQZ Biotechnologies Company | 50.03 Million USD | -4755.735% |
| Evofem Biosciences, Inc. | 72.47 Million USD | -3252.736% |
| Santhera Pharmaceuticals Holding AG | 59.01 Million USD | -4017.259% |
| Mesoblast Limited | 188.44 Million USD | -1189.377% |
| Propanc Biopharma, Inc. | 3.85 Million USD | -62987.341% |
| Genus plc | 485 Million USD | -400.982% |
| VioQuest Pharmaceuticals, Inc. | 5.84 Million USD | -41486.832% |
| CNBX Pharmaceuticals Inc. | 2.51 Million USD | -96459.789% |
| Marizyme, Inc. | 26.67 Million USD | -9008.514% |
| ContraFect Corporation | 32.53 Million USD | -7369.063% |
| Nymox Pharmaceutical Corporation | 3.8 Million USD | -63841.079% |
| PsyBio Therapeutics Corp. | 1.98 Million USD | -122534.189% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 3.82 Million USD | -63379.218% |
| Intellipharmaceutics International Inc. | 12 Million USD | -20133.226% |
| AXIM Biotechnologies, Inc. | 11.77 Million USD | -20529.315% |
| MultiCell Technologies, Inc. | 1617.67 USD | -150201177.146% |
| Accustem Sciences Inc. | 1.07 Million USD | -225036.508% |
| RVL Pharmaceuticals plc | 77.41 Million USD | -3038.537% |
| EV Biologics, Inc. | 2.11 Million USD | -114778.569% |
| Q BioMed Inc. | 8.13 Million USD | -29775.559% |
| Emmaus Life Sciences, Inc. | 82.93 Million USD | -2829.717% |
| Neon Bloom, Inc. | 1.22 Million USD | -198051.626% |
| Mosaic ImmunoEngineering Inc. | 5.14 Million USD | -47116.177% |
| Biomind Labs Inc. | 1.49 Million USD | -162034.095% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 244.07 Million USD | -895.506% |
| Oncotelic Therapeutics, Inc. | 18.4 Million USD | -13102.772% |
| Skye Bioscience, Inc. | 14.07 Million USD | -17166.355% |
| Therapeutic Solutions International, Inc. | 2.01 Million USD | -120775.814% |
| THC Farmaceuticals, Inc. | 142.09 Thousand USD | -1709855.312% |
| Arch Therapeutics, Inc. | 9.46 Million USD | -25568.511% |
| IMV Inc. | 37.93 Million USD | -6305.436% |
| Acro Biomedical Co., Ltd. | 201.11 Thousand USD | -1208039.084% |
| Curative Biotechnology, Inc. | 5.74 Million USD | -42187.447% |
| GB Sciences, Inc. | 5.41 Million USD | -44749.754% |
| Alpha Cognition Inc. | 7.16 Million USD | -33812.598% |
| HST Global, Inc. | 593.59 Thousand USD | -409231.141% |
| CSL Limited | 18.62 Billion USD | 86.952% |
| Halberd Corporation | 728.71 Thousand USD | -333329.072% |
| Enzolytics Inc. | 365.26 Million USD | -565.198% |
| Resverlogix Corp. | 67.39 Million USD | -3505.201% |
| Affymax, Inc. | 8.87 Million USD | -27289.933% |
| SYBLEU INC | 681.41 Thousand USD | -356476.848% |
| Nuo Therapeutics, Inc. | 838.73 Thousand USD | -289594.563% |
| argenx SE | 444.95 Million USD | -446.074% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 74.92 Million USD | -3143.141% |
| Enzon Pharmaceuticals, Inc. | 1.71 Million USD | -141659.685% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 11.9 Million USD | -20312.84% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.66 Million USD | -66193.377% |
| AVAX Technologies, Inc. | 3.99 Million USD | -60739.162% |
| Zenith Capital Corp. | 27.56 Thousand USD | -8813280.971% |
| Genscript Biotech Corporation | 1.32 Billion USD | -83.258% |
| Ember Therapeutics, Inc. | 238.65 Thousand USD | -1018010.319% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 3.73 Million USD | -64965.932% |
| WPD Pharmaceuticals Inc. | 680.83 Thousand USD | -356780.091% |
| American Oriental Bioengineering, Inc. | 118.72 Million USD | -1946.593% |
| Provectus Biopharmaceuticals, Inc. | 9.04 Million USD | -26771.366% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 66.92 Thousand USD | -3630256.049% |
| GlobeStar Therapeutics Corporation | 1.43 Million USD | -169355.826% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 50.26 Million USD | -4733.998% |
| Cotinga Pharmaceuticals Inc. | 2.71 Million USD | -89504.819% |
| BioStem Technologies, Inc. | 15.9 Million USD | -15177.032% |
| ONE Bio Corp. | 27.49 Million USD | -8736.841% |
| Reve Technologies, Inc. | 464.69 Thousand USD | -522767.706% |
| Burzynski Research Institute, Inc. | 27.43 Thousand USD | -8856973.597% |
| Wesana Health Holdings Inc. | 1.25 Million USD | -192861.762% |
| Agentix Corp. | 2.51 Million USD | -96681.827% |
| LadRx Corporation | 2.2 Million USD | -110317.182% |
| Cell Source, Inc. | 15.8 Million USD | -15271.702% |
| ProtoKinetix, Incorporated | 44.69 Thousand USD | -5436093.395% |
| Regen BioPharma, Inc. | 5.45 Million USD | -44420.556% |
| Regen BioPharma, Inc. | 5.45 Million USD | -44420.556% |
| NovAccess Global Inc. | 7.86 Million USD | -30810.111% |
| Endonovo Therapeutics, Inc. | 24.74 Million USD | -9718.792% |
| Itoco Inc. | 1.65 Million USD | -146877.56% |
| Rasna Therapeutics, Inc. | 2.05 Million USD | -118334.512% |
| Pathfinder Cell Therapy, Inc. | 6.04 Million USD | -40067.978% |
| Kadimastem Ltd | 3.5 Million USD | -69225.341% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 421.56 Thousand USD | -576262.769% |
| CytoDyn Inc. | 127.89 Million USD | -1799.824% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 41.79 Thousand USD | -5812864.425% |
| Mobile Lads Corp. | 1.31 Million USD | -184884.13% |
| NanoSphere Health Sciences Inc. | 1.56 Million USD | -155019.808% |
| Qrons Inc. | 1.48 Million USD | -163112.184% |
| Alseres Pharmaceuticals, Inc. | 11.04 Million USD | -21898.166% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 808.79 Thousand USD | -300317.783% |
| Rebus Holdings, Inc. | 5.24 Million USD | -46251.793% |
| ImmunoCellular Therapeutics, Ltd. | 6.1 Million USD | -39719.712% |
| International Stem Cell Corporation | 5.27 Million USD | -45944.362% |
| Bioxytran, Inc. | 3.24 Million USD | -74673.381% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 625.8 Thousand USD | -388159.197% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 4.61 Million USD | -52524.978% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 40.99 Million USD | -5826.825% |
| Adhera Therapeutics, Inc. | 22.26 Million USD | -10812.917% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 2.02 Million USD | -119865.271% |
| Innovation Pharmaceuticals Inc. | 5.47 Million USD | -44254.892% |
| Neutra Corp. | 973.52 Thousand USD | -249482.806% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -8274.155% |
| PureTech Health plc | 125.58 Million USD | -1834.785% |
| Coeptis Therapeutics, Inc. | 3.75 Million USD | -64570.752% |
| IXICO plc | 1.9 Million USD | -127762.507% |
| IntelGenx Technologies Corp. | 20.52 Million USD | -11735.749% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -2251.594% |
| CSL Limited | 18.62 Billion USD | 86.952% |
| Cellectis S.A. | 249.36 Million USD | -874.362% |